News-Medical.Net

Advancing drug discovery with AI, generative chemistry, and 3D molecular design

We develop cutting-edge software and AI solutions for small molecule design, optimization and data analysis. Our mission is ...
KTLA

Elix Provides AI Drug Discovery Platform "Elix Discovery™" to KYORIN Pharmaceutical

TOKYO, JAPAN, August 20, 2025 /EINPresswire.com/ -- Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”), a Japan-based AI drug discovery ...
C&EN

Qsarna: An Online Tool for Smart Chemical Space Navigation in Drug Design

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Drug discovery is a lengthy and resource-intensive process that requires innovative ...
Morningstar

Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Eisai

Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix Discovery™ (https://www ...
C&EN

Advancing Covalent Ligand and Drug Discovery beyond Cysteine

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. In this review, we discuss both historical and recent advances ...
JD Supra

Navigating Inventorship in the Era of AI-Assisted Drug Discovery

This post is part of MoFo’s 2025 Intersection of AI and Life Sciences blog series. In this blog series, we explore how artificial intelligence is revolutionizing research, innovation, and patient care ...
IEEE

Dual Channel based Convolutional Neural Network based Protein–Ligand Interaction Prediction for Drug Design

Abstract: Nowadays, the drug discovery and drug design is developing to yield safe drugs constantly based on time, labor efficient way and cost. In drug discovery, the binding affinity and interaction ...